No Data
Taysha Gene Therapies Announces Oral Presentation on TSHA-102 in Rett Syndrome at Upcoming 9th World Rett Syndrome Congress
Express News | Taysha Gene Therapies Announces Oral Presentation on Tsha-102 in Rett Syndrome at Upcoming 9TH World Rett Syndrome Congress
Truist Financial Maintains Taysha Gene Therapies(TSHA.US) With Buy Rating
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Taysha Gene Therapies Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag